What is the role of WHO in LF elimination?
The fiftieth World Health Assembly (1997) adopted a resolution WHA50.29 calling upon Member states to bestow greater attention to the problem of LF and work towards its elimination as a public health problem. In order to support the elimination efforts, the Global Alliance to Eliminate Lymphatic Filariasis (GAELF), was formed. GAELF is a partnership of many organizations, including major donors and national governments. At the Regional level, the Regional Programme Review Group (RPRG) was formed in 2001 following a Memorandum of Understanding (MoU) between drug donor, GlaxoSmithKline, and WHO. The RPRG serves as a technical advisory group and also as an approving body for free supply of MDA drugs. WHO functions as the secretariat to the RPRG.